Protamine use in transcarotid artery revascularization is associated with lower risk of bleeding complications without higher risk of thromboembolic events
Patric Liang, Raghu L. Motaganahalli, Mahmoud B. Malas, Grace J. Wang, Jens Eldrup-Jørgensen, Jack L. Cronenwett, Brian Nolan, Vikram S. Kashyap, Marc L. Schermerhorn
Topics & Concepts
MedicineProtamineRevascularizationCardiologyInternal medicineHeparinMyocardial infarctionCerebrovascular and Carotid Artery DiseasesPeripheral Artery Disease ManagementCoronary Interventions and Diagnostics